Kwame Owusu-Edusei Jr
Overview
Explore the profile of Kwame Owusu-Edusei Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
646
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Owusu-Edusei Jr K, McClendon-Weary B, Bull L, Gift T, Aral S
Sex Transm Dis
. 2019 Dec;
47(3):165-170.
PMID: 31842088
Background: The association between county-level social capital indices (SCIs) and the 3 most commonly reported sexually transmitted infections (STIs) in the United States is lacking. In this study, we determined...
2.
Owusu-Edusei Jr K, Chang B
Sex Transm Dis
. 2019 Nov;
46(12):771-776.
PMID: 31688724
Purpose: To identify and examine the correlates of multiple bacterial sexually transmitted infection (STI) hot spot counties in the United States. Methods: We assembled and analyzed 5 years (2008-2012) of...
3.
Owusu-Edusei Jr K, Chang B, Aslam M, Johnson R, Pearson W, Chesson H
Sex Health
. 2019 Mar;
16(2):148-157.
PMID: 30885293
Methods: We obtained multiyear (2008-12) cross-sectional county-level data on violent crime and three STIs (chlamydia, gonorrhoea, and primary and secondary (P&S) syphilis) from counties in all the contiguous states in...
4.
Chesson H, Kirkcaldy R, Gift T, Owusu-Edusei Jr K, Weinstock H
Sex Transm Dis
. 2018 Feb;
45(4):250-253.
PMID: 29465709
Preventing the emergence of ceftriaxone-resistant Neisseria gonorrhoeae can potentially avert hundreds of millions of dollars in direct medical costs of gonorrhea and gonorrhea-attributable HIV infections. In the illustrative scenario we...
5.
Chesson H, Owusu-Edusei Jr K
Sex Transm Dis
. 2018 Feb;
45(9S Suppl 1):S72-S77.
PMID: 29465641
Background: Improvements in resource allocation can increase the benefits of federally funded sexually transmitted disease (STD) prevention activities. The purpose of this study was to illustrate how different strategies for...
6.
Owusu-Edusei Jr K, Winston C, Marks S, Langer A, Miramontes R
Tuberc Res Treat
. 2018 Jan;
2017:3816432.
PMID: 29326845
Objective: To evaluate TB test usage and associated direct medical expenditures from 2013 private insurance claims data in the United States (US). Methods: We extracted outpatient claims for TB-specific and...
7.
Owusu-Edusei Jr K, Gift T, Leichliter J, Romaguera R
Sex Transm Dis
. 2017 Sep;
45(2):81-86.
PMID: 28876293
Background: The number of categorical sexually transmitted disease (STD) clinics is declining in the United States. Federally qualified health centers (FQHCs) have the potential to supplement the needed sexually transmitted...
8.
Chang B, Pearson W, Owusu-Edusei Jr K
Ann Epidemiol
. 2017 Mar;
27(4):231-237.
PMID: 28302356
Purpose: We used a combination of hot spot analysis (HSA) and spatial regression to examine county-level hot spot correlates for the most commonly reported nonviral sexually transmitted infections (STIs) in...
9.
Owusu-Edusei Jr K, Hoover K, Gift T
Am J Prev Med
. 2016 Mar;
51(2):216-224.
PMID: 26952078
Introduction: In spite of chlamydia screening recommendations, U.S. testing coverage continues to be low. This study explored the cost-effectiveness of a patient-directed, universal, opportunistic Opt-Out Testing strategy (based on insurance...
10.
Fan L, Owusu-Edusei Jr K, Schillie S, Murphy T
Hepatology
. 2015 Oct;
63(5):1471-80.
PMID: 26509655
Unlabelled: In an era of antiviral treatment, reexamination of the cost-effectiveness of strategies to prevent perinatal hepatitis B virus (HBV) transmission in the United States is needed. We used a...